İ | English
 

API

Intermediates

Custom synthesis

  Apixaban
  Aprepitant
  Bepotastine besylate
  Bisoprolol Fumarate
  Clomifene Citrate
  Cyclophosphamide
  Darifenacin HBr
  Dronedarone Base
  Dronedarone Hydrochloride
  Dasatinib
  Dasatinib monohydrate
  Deferasirox
  Febuxostat
  Fesoterodine fumarate
  Ivabradine Hydrochloride
  Indacaterol
  Lafutidine
  Leucovorin Calcium
  L-Leucovorin Calcium
  Methotrexate
  Mizolastine
  Olopatadine Hydrochloride
  Prasugrel Hydrochloride
  Prasugrel base
  Paricalcitol
  Rivaroxaban
  Silodoxin
  Tamoxifen Citrate
  Voriconazole
  Voglibose
  Calcitonin
  Desmopressin
  Terlipressin
  Enfuvirtide(T-20)
  Eptifibatide
  Glucagon
  Gonadorelin
  Goserelin
  Hexarelin
  Leuprorelin
  Melanotan
  Octreotide
  Sermorelin
  Somatostatin
  Thymopentin
  1Thymosin alpha-1
  Triptorelin
  Buserelin
  Deslorelin
  Fertirelin
  Nafarelin
  Alarelin
  Histrelin
  Bivalirudin
  Nesiritide
  Exenatide
  Pramlintide
  Liraglutide
  1H-Inden-2-amine,5,6-diethyl-2,3-dihydro-,hydrochloride (1:1)
  4-(4-Aminophenyl)morpholin-3-one(For Ivabradine)
  (S)-N-(2, 3-Epoxypropyl)phthalimide(For Ivabradine)
  3,4-dimethoxy-N-methyl-bicyclo[4.2.0]octa-1,3,5-triene-7-methanamine hydrochloride (For Ivabradine)
  3-(3-chloropropyl)-1,3-dihydro-7,8-dimethoxy-2H-3-Benzazepin-2-one(For Ivabradine)
  Methanone, (2-butyl-5-nitro-3-benzofuranyl)[4-[3-(dibutylamino)propoxy]phenyl](For Dronedarone)
  (5-Amino-2-butyl-3-benzofuranyl)[4-[3-(dibutylamino)propoxy]phenyl]-methanone dioxalate(For Dronedarone)
  2-Butyl-3-(4-methoxybenzoyl)-5-nitrobenzofuran(For Dronedarone)
  2-(n-Butyl)-3-(4-hydroxybenzoyl)-5-nitrobenzofuran(For Dronedarone)
  N-(3-Chloropropyl)dibutylamine(For Dronedarone)
  Ethyl 4-[(4-chlorophenyl)-2-pyridinylmethoxy]-1-piperidinecarboxylate(For Bepotastine)
  2-[(4-Chlorophenyl)(4-piperidinyloxy)methyl]-pyridine(For Bepotastine)
  2-[(4-chlorophenyl)(4-piperidinyloxy)methyl]-pyridine 4-nitrobenzoate
  6-ethyl-5-fluoro-4-hydroxypyrimidine(For Voriconazole)
  4-chloro-6-ethyl-5-fluoropyrimidine(For Voriconazole)
  (2R,3S/2S,3R)-3-(4-Chloro-5-fluoro-6-pyrimidinyl)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)-2-butanol hydrochloride (For Voriconazole)
  (2R,3S/2S,3R)-2-(2,4-difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-(1H-1,2,4-triazol-1-yl)-2-butanol (Racemic Voriconazole)
  4-[(2-carboxyphenyl)methoxy]benzeneacetic acid (For Olopatadine)
  6,11-dihydro-11-oxo-dibenz[b,e]oxepin-2-acetic acid(For Olopatadine)
  [3-(dimethylamino)propyl]triphenylphosphonium bromide hydrobromide (For Olopatadine)
  N-{4-[4-(piperidinomethyl)pyridyl-2-oxy]-cis-2-butene}phthalimide Maleate(For Lafutidine)
  2-Chloro-4-(piperidin-1-ylmethyl)pyridine Oxalate(For Lafutidine)
  p-nitrophenyl 2-(furfurylsulfinyl)acetate(For Lafutidine)
  5,6,7,8-tetrahydro-2-naphthol(For Liranaftate)
  2,3-dihydrobenzofuranyl-5-acetic acid(For Darifenacin)
  5-(2-bromoethyl)-2,3-dihydrobenzofuran (For Darifenacin)
  (s)-2,2-diphenyl-2-(1-tosylpyrrolidin-3-yl)acetonitrile(For Darifenacin)
  2,2-Diphenyl-2-[(3S)-pyrrolidin-3-yl]acetamide L-(+)-tartrate (For Darifenacin)
  Ethyl 2-(3-formyl-4-hydroxyphenyl)-4-methyl-5-Thiazolecarboxylate(For Febuxostat)
  Ethyl 2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methyl-5-Thiazolecarboxylate(For Febuxostat)
  KRP-2032-Amino-2-(2-(4-(3-benzyloxyphenylthio)-2-chlorophenyl)ethyl)-1,3-propanediol hydrochloride
  1H-Indole-7-boronic acid
  38. 2-(Chloromethyl)-3-(trifluoromethyl)pyridine
  Aromadendrin
  Diphenyleneiodonium Sulfate
  Ethyl 4-bromothiazole-2-carboxylate
  1-(2-Methylpyrimidin-5-yl)ethanamine
  3-Chloromethyl-1,2,4-oxadiazole
  5-Chloropyrazine-2-carbaldehyde
  2,3-Pyridinedicarboxylicacid,4-amino-,dimethylester
  Methyl 3-amino-5,6-dimethylpyrazine-2-carboxylate
  Ethyl 3-amino-4-methoxythieno[2,3-b]pyridine-2-carboxylate
  Ethyl 3-amino-5-nitrothieno[2,3-b]pyridine-2-carboxylate
  1-(5-Methylpyrimidin-2-yl)ethanol
  7-Chloro-5-methoxy-Thieno[3,2-b]pyridine
  2-Bromo-7-chloro-thieno[3,2-b]pyridine
  5-Bromo-2,3-dihydro-1H-inden-2-ol
  5,7-Dichloro-pyrido[4,3-d]pyrimidin-4(3H)-one
  3-Bromo-5-methyl-1H-pyrazole
  Lumiracoxib
  Asenapine
  Lurasidone
  Lurasidone
  Lurasidone HCl
  Posaconazole
  Alvimopan
  Rivastigmine tartrate
  Rasagiline mesylate
  H-L-Asu-OH
  5-[(2R)-2-Aminopropyl]-1-[3-(benzoyloxy)propyl]-2,3-dihydro-1H-indole-7-carbonitrile (2R,3R)-2,3-dihydroxybutanedioate(for Silodoxin)
  2-[2-(2,2,2-Trifluoroethoxy)phenoxy]ethyl methanesulfonate(for Silodoxin)
  Cyclopropyl-2-fluorobenzyl ketone (for Prasugrel)
  5,6,7,7a-Tetrahydrothieno[3,2-c]pyridin-2(4H)-one 4-methylbenzenesulfonate (for Prasugrel)
  5,6,7,7a-Tetrahydro-5-(triphenylmethyl)thieno[3,2-c]pyridinone(for Prasugrel)
  4-(2-Hydroxyethyl)oxyindole(forRopinirole)
  2,3,4,6-Tetra-O-benzyl-alpha-D-glucose (forVoglibose)
  Tetrabenzyl-voglibose(forVoglibose)
  4,5-Dimethoxy-1-cyanobenzocyclobutane
  (S)-4-[1-(4-Chlorophenyl)-1-(2-pyridyl) methoxy] piperidine (For Bepotastine)
  Landiolol HCl
  ((S)-2,2-Dimethyl-1,3-dioxolan-4-yl)methyl 3-(4-hydroxyphenyl)propanoate
  (S)-(+)-Glycidyl nosylate
  N-(2-Aminoethyl)-4-morpholinecarboxamide ethanedioate
  methotrexate disodium
  2,4,5,6-Tetraaminopyrimidine sulfate
  2,4-diamino-6-(bromomethyl)pteridine
  2,3,4,6-Tetra-O-benzyl-D-glucopyranose(for Voglibose)
  8-benzyloxy-5-(2-bromoacetyl)-2-(1H)-quinolinone) (for indacaterol)
  (3aR,4S,7R,7aS)-rel-Hexahydro-4,7-methano-1H-isoindole-1,3(2H)-dione(for Lurasidone) 
  (3R,4R)-3,4-Dimethyl-4-(3-hydroxyphenyl)piperidine(for Alvimopan)
  (alphaS,3R,4R)-4-(3-Hydroxyphenyl)-3,4-dimethyl-alpha-(phenylmethyl)-1-piperidinepropanoic acid methyl ester(for Alvimopan ) 
  (R)-2-Benzyl-3-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]propanoic acid(for Alvimopan)
  Entecavir
  2-[(S)-(4-chlorophenyl)(4-piperidinyloxy)methyl]-pyridine (For Bepotastine)
  (5R-cis)-Toluene-4-sulfonic acid 5-(2,4-difluorophenyl)-5-(1H-1,2,4-triazol-1-yl)methyltetrahydrofuran-3-ylmethyl ester
  2-[(1S,2S)-1-Ethyl-2-bezyloxypropyl]-2,4-dihydro-4-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]-3H-1,2,4-triazol-3-one
  Pidotimod
  Raltitrexed
  Pemetrexed disodium
  olmesartan medoxomil
  Doxofylline
  Anagrelide Hydrochloride
  Anagrelide
  pramipexole dihydrochloride
  Trans-(+/-)-11-Chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrole-1-one
  11-chloro-2,3-dihydro-2-methyl-1H-dibenz[2,3;6,7]oxepino[4,5-c]pyrrol-1-one
  (5-Chloro-2-phenoxyphenyl)acetic acid
  Trans-5-chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-Dibenz[2,3:6,7]oxepino[4,5-c]pyrrol-1-one
  Cis-5-chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-Dibenz[2,3:6,7]oxepino[4,5-c]pyrrol-1-one
  Mixture of Trans and Cis-5-chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-Dibenz[2,3:6,7]oxepino[4,5-c]pyrrol-1-one
  5-Chloro-2-Methyl-2,3-Dihydro-Benzo-[2,3:6,7]-Oxepino-[4,5-C]-pyrrole-(2H)-One
  Dabigatran etexilate mesylate
  Dabigatran etexilate
  3-[(3-Amino-4-methylaminobenzoyl)pyridin-2-ylamino]propionic acid ethyl ester
  N-(4-Cyanophenyl)glycine
  Benzoic acid, 4-(methylamino)-3-nitro
  Ethyl 3-(pyridin-2-ylamino)propanoate
  2-(4-Methoxy-1,4-cyclohexadienyl)-2-propanol(for Nabilone)
  5-(1,1-Dimethylheptyl)resorcinol(for Nabilone)
  2-Hydroxyquinoline-4-carboxylic acid
  Tetraisopropyl methylenediphosphonate(for Disodium clodronate)
  Di(N-succinimidyl) adipate
  TRI(ETHYLENE GLYCOL) DI-P-TOLUENESULFONATE
  (S)-3-(5-(2-aminopropyl)-7-cyanoindolin-1-yl)propyl benzoate(2S,3S)-2,3-dihydroxysuccinate
  5-[(2R,S)-2-AMINOPROPYL]-1-[3-(BENZOYLOXY)PROPYL]-2,3-DIHYDRO-1H-INDOLE-7-CARBONITRILE
  (R)-tetrahydrothiophen-3-ol
  ethyl 4-(4-hydroxypiperidin-1-yl) butanoate
  (S)-(4-chlorophenyl)(pyridine-2yl)methanol (S form)
  ethyl 4-(4-bromoypiperidin-1-yl)butanoate
  Benzothiophene-3-carboxylic acid
  Edoxaban tosylate monohydrate
  Edoxaban
  4,5,6,7-tetrahydro-5-Methyl-Thiazolo[5,4-c]pyridine-2-carboxylic acid hydrochloride
  Carbamic acid, N-[(1R,2S,5S)-2-[[2-[(5-chloro-2-pyridinyl) amino]-2-oxoacetyl]amino]-5-[(dimethylamino)carbonyl]cyclohexyl]-, 1,1-dimethylethyl ester
  Carbamic acid,[(1R,2S,5S)-2-amino-5-[(dimethylamino)carbonyl]cyclohexyl]-,1,1-dimethylethyl ester
  N-[3-fluoro-4-[(methylamino)carbonyl]phenyl]-2-methyl-alanine
  N-[3-fluoro-4-[(methylamino)carbonyl]phenyl]-2-methyl-alanine methyl ester
  4-Isothiocyanato-2-(trifluoromethyl)benzonitrile
  Enzalutamide
  Naphthalene,1-cyclopropyl-4-isothiocyanato-
  THR-PHE-GLN-ALA-TYR-PRO-LEU-ARG-GLU-ALA
  esinurad
  (R)-3-aminobutan-1-ol
  1533519-85-5
  Apremilast
  N-(1,3-dioxo-1,3-dihydro-isobenzofuran-4-yl)acetamide
  4-(4-cyclopropylnaphthalen-1-yl)-1H-1,2,4-triazole-5(4H)-thione
  Acotiamide hydrochloride
  138530-94-6
  MK-4305
  FYX 051
  6-Ethylchenodeoxycholic acid
Our goal is to become a fully-integrated biopharmaceutical company and a leader in the discovery, development and commercialization of novel small molecule drugs. Key components of our strategy to achieve our corporate goals are outlined below.

Build and advance our product candidate pipeline. Through our drug discovery and development programs, we have created a broad pipeline of drug candidates spanning a range of therapeutic areas. We plan to continue to aggressively pursue the development and commercialization of these drug candidates. In addition, we believe that the breadth of our capabilities in drug discovery technology will enable us to continue to identify and develop additional drug candidates on an efficient and rapid basis.

Establish strategic alliances with academic institutes and leading pharmaceutical companies. We have established, and expect to continue to build upon, a broad set of strategic alliances with several academic institutes and leading pharmaceutical companies. These collaborations have enabled us to leverage our expertise into additional therapeutic areas, benefit from the therapeutic area expertise and commercial resources of our partners, and augment our financial resources.

Expand our development expertise. From our origins as a drug discovery organization, we have steadily expanded our capabilities in drug development. As we advance our product candidate pipeline, we plan to further augment our development team by adding additional personnel with experience in drug safety, regulatory affairs, statistical methods, project management and medical affairs.

Establish specialized sales and marketing capabilities. We plan to retain China and United States marketing and sales rights or co-promotion rights for our product candidates.
     
2009-2011 BEIJING EAGLE SKY PHARMATECH CO., LTD  |  Tel: 0086-10-59799429 Fax: 0086-10-58043698
Address: Rm 323, Building 3, Yard A, No. 4, Yongding Rd Jia , Haidian District, Beijing 100039, China
Web: www.eagleskypharmatech.com  |  E-mail: Contact@EagleSkyPharmatech.com  |  marketing@EagleSkyPharmatech.com
 ICP09110018  Supported by: www.hxchem.net